Effect of Platelet-Rich Plasma (PRP) in the treatment of androgenic hair loss

The evaluation of effect of Platelet-Rich Plasma (PRP) in the treatment of patients with androgenic alopecia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160318027097N11

Enrollment

Registered

2018-06-02

Start date

2018-06-05

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic alopecia. Androgenic alopecia

Interventions

Intervention group: Platelet-Rich Plasma (PRP), 0.1 ml/cm2, Interfollicular injection, 3 times in each patient in selected areas of the scalp at intervals of 30 days..

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18–60 years Male pattern hair loss (MPHL) Indication of the participant for PRP injection

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The androgenic alopecia clinical manifestations. Timepoint: Before the intervention, 2 weeks, 1 month, 3 months after the intervention. Method of measurement: Clinical examinations and dermoscopy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Efat Khodayan

Tabriz University of Medical Sciences

naghizadeh73@yahoo.com+98 45 3351 2006

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026